Literature DB >> 26340900

Advances in the study of transmissible respiratory tumours in small ruminants.

M Monot1, F Archer1, M Gomes1, J-F Mornex2, C Leroux3.   

Abstract

Sheep and goats are widely infected by oncogenic retroviruses, namely Jaagsiekte Sheep RetroVirus (JSRV) and Enzootic Nasal Tumour Virus (ENTV). Under field conditions, these viruses induce transformation of differentiated epithelial cells in the lungs for Jaagsiekte Sheep RetroVirus or the nasal cavities for Enzootic Nasal Tumour Virus. As in other vertebrates, a family of endogenous retroviruses named endogenous Jaagsiekte Sheep RetroVirus (enJSRV) and closely related to exogenous Jaagsiekte Sheep RetroVirus is present in domestic and wild small ruminants. Interestingly, Jaagsiekte Sheep RetroVirus and Enzootic Nasal Tumour Virus are able to promote cell transformation, leading to cancer through their envelope glycoproteins. In vitro, it has been demonstrated that the envelope is able to deregulate some of the important signaling pathways that control cell proliferation. The role of the retroviral envelope in cell transformation has attracted considerable attention in the past years, but it appears to be highly dependent of the nature and origin of the cells used. Aside from its health impact in animals, it has been reported for many years that the Jaagsiekte Sheep RetroVirus-induced lung cancer is analogous to a rare, peculiar form of lung adenocarcinoma in humans, namely lepidic pulmonary adenocarcinoma. The implication of a retrovirus related to Jaagsiekte Sheep RetroVirus is still controversial and under investigation, but the identification of an infectious agent associated with the development of lepidic pulmonary adenocarcinomas might help us to understand cancer development. This review explores the mechanisms of induction of respiratory cancers in small ruminants and the possible link between retrovirus and lepidic pulmonary adenocarcinomas in humans.
Copyright © 2015. Published by Elsevier B.V.

Entities:  

Keywords:  Cancer; ENTV; Goat; JSRV; Lepidic; Respiratory infection; Retrovirus; Sheep

Mesh:

Year:  2015        PMID: 26340900     DOI: 10.1016/j.vetmic.2015.08.008

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  7 in total

Review 1.  Mouse Mammary Tumour Virus (MMTV) in Human Breast Cancer-The Value of Bradford Hill Criteria.

Authors:  James S Lawson; Wendy K Glenn
Journal:  Viruses       Date:  2022-03-30       Impact factor: 5.818

2.  Clinical, molecular, and pathological investigations of ovine pulmonary adenocarcinoma in the middle of Iraq.

Authors:  Falah Abd Abass; Yahia Ismail Khudhair
Journal:  Open Vet J       Date:  2022 Mar-Apr

3.  Evidence of jaagsiekte sheep retrovirus-induced pulmonary adenocarcinoma in Ouled Djellal breed sheep in Algeria.

Authors:  Nour El Houda Belalmi; Nassim Sid; Omar Bennoune; Soraya Ouhida; Marcelo De Las Heras; Caroline Leroux
Journal:  Vet Res Forum       Date:  2020       Impact factor: 1.054

4.  Mammary carcinoma arising in an adenoma in a ewe.

Authors:  Shelley J Newman; Stephen A Smith; Kurt Zimmerman
Journal:  J Vet Diagn Invest       Date:  2021-02-12       Impact factor: 1.279

5.  First case report of enzootic nasal adenocarcinoma in "Ouled Djellal" ewe in Algeria.

Authors:  Nassim Sid; Nour El Houda Belalmi; Louiza Benhamza; Soraya Ouhida; Mohammed Ezine Zebiri; Ahmet Aydoğan; Caroline Leroux
Journal:  Open Vet J       Date:  2018-01-19

6.  Blocked expression of key genes of the angiogenic pathway in JSRV-induced pulmonary adenocarcinomas.

Authors:  Maryline Gomes; Fabienne Archer; Nicolas Girard; Barbara Gineys; Christine Dolmazon; Alexandra Bobet Erny; Jean-François Mornex; Caroline Leroux
Journal:  Vet Res       Date:  2017-11-14       Impact factor: 3.683

Review 7.  Neoplasia-Associated Wasting Diseases with Economic Relevance in the Sheep Industry.

Authors:  Marcelo De Las Heras; Marta Borobia; Aurora Ortín
Journal:  Animals (Basel)       Date:  2021-02-03       Impact factor: 2.752

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.